跳至主要内容
临床试验/NCT01824732
NCT01824732Unknown不适用

a Study of Clinical Safety Monitoring and the Mechanism of Anaphylactic Reaction Used Tanreqing(a Chinese Medicine Injection)in Hospitals in China

China Academy of Chinese Medical Sciences1 个研究点 分布在 1 个国家目标入组 3,000 人开始时间: 2013年1月最近更新:
适应症

试验速览

阶段
不适用
入组人数
3,000
试验地点
1
主要终点
Number of participants with anaphylactic reaction;the blood of participants with anaphylactic reaction

研究概览

简要总结

This study was advocated by Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences in December 2012.

The purpose of this study is to make a event monitoring to see whether Tanreqing injection is safe and the characteristic and mechanism of anaphylactic reaction used Tanreqing injection in hospitals in China.

详细描述

It is very common that Chinese Medicine Injection used in hospitals in mainland China. However safety problems rose in recent years. There could be many uncertain factors influence Chinese Medicine Injection in clinical practice.

In order to ensure the safety of public drug use and lower drug-induced risks, a registry study for Tanreqing injection safety surveillance with 3000 patients will be conducted from Jan.2013 to Mar.2013.At the same time,Patients who have anaphylactic reaction are selected as the allergic group and not have anaphylactic reaction are selected as the control group.The proportion of allergic group and control group is 1:4.All the patients who are selected should draw blood.

Eligibility criteria Patients who will use Tanreqing injection in selected hospitals.

研究设计

研究类型
Observational
时间视角
Prospective

入排标准

年龄范围
1 Month 至 80 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients using Tanreqing injection from January to March 2013

排除标准

  • 未提供

结局指标

主要结局

Number of participants with anaphylactic reaction;the blood of participants with anaphylactic reaction

时间窗: to assess Tanreqing's 'anaphylactic reaction' .during patients' hospital stay, administration information of Tanreqing will be registered every day. The registry procedure will last 3 month only for patients using Tanreqing

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Yanming Xie

Director

China Academy of Chinese Medical Sciences

研究点 (1)

Loading locations...

相似试验